Inventor
Bret Benton
Inventor
Burlingame, CA, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms78%
C07KPeptides11%
C12NMicroorganisms or enzymes11%
PatentTitleYear
6,638,718'Methods of screening for compounds active on staphylococcus aureus target genes'20036,630,303'Methods of screening for compounds active on Staphylococcus aureus target genes'20036,514,746'Staphylococcus aureus histidine protein kinase essential genes'20036,228,588'Methods of screening for compounds active on Staphylococcus aureus target genes'20016,187,541'Methods of screening for compounds active on staphylococcus aureus target genes'20016,037,123'Methods of screening for compounds active on Staphylococcus aureus target genes'20005,962,249'Sized-based marker identification technology'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2001Patents assigned to MICROCIDE PHARMACEUTICALS INC (4)· patent assignee history
1999–2003Based in Burlingame, CA, US· patent location history
2003Patents assigned to ESSENTIAL THERAPEUTICS INC (3)· patent assignee history
2003Based in San Bruno, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MICROCIDE PHARMACEUTICALS INC | 4 | 1999–2001 |
| ESSENTIAL THERAPEUTICS INC | 3 | 2003 |
Locations
| Location | Patents | Span |
|---|---|---|
| Burlingame, California, US | 6 | 1999–2003 |
| San Bruno, California, US | 1 | 2003 |